Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Effect of Disulfiram and Copper Plus Chemotherapy vs Chemotherapy Alone on Survival in Patients With Recurrent Glioblastoma: A Randomized Clinical Trial.
JAMA Netw Open. 2023 Mar 1;6(3):e234149. doi: 10.1001/jamanetworkopen.2023.4149.
JAMA Netw Open. 2023.
PMID: 37000452
Free PMC article.
Clinical Trial.
Disulfiram repurposing combined with nutritional copper supplement as add-on to chemotherapy in recurrent glioblastoma (DIRECT): Study protocol for a randomized controlled trial.
Jakola AS, Werlenius K, Mudaisi M, Hylin S, Kinhult S, Bartek J Jr, Salvesen Ø, Carlsen SM, Strandéus M, Lindskog M, Löfgren D, Rydenhag B, Carstam L, Gulati S, Solheim O, Bartek J, Solheim T.
Jakola AS, et al. Among authors: mudaisi m.
F1000Res. 2018 Nov 15;7:1797. doi: 10.12688/f1000research.16786.1. eCollection 2018.
F1000Res. 2018.
PMID: 30647912
Free PMC article.
Item in Clipboard
ABCB1 single-nucleotide variants and survival in patients with glioblastoma treated with radiotherapy concomitant with temozolomide.
Malmström A, Łysiak M, Åkesson L, Jakobsen I, Mudaisi M, Milos P, Hallbeck M, Fomichov V, Broholm H, Grunnet K, Poulsen HS, Bratthäll C, Strandeus M, Papagiannopoulou A, Stenmark-Askmalm M, Green H, Söderkvist P.
Malmström A, et al. Among authors: mudaisi m.
Pharmacogenomics J. 2020 Apr;20(2):213-219. doi: 10.1038/s41397-019-0107-z. Epub 2019 Oct 17.
Pharmacogenomics J. 2020.
PMID: 31624332
Item in Clipboard
Assessment of genetic and non-genetic risk factors for venous thromboembolism in glioblastoma - The predictive significance of B blood group.
Heenkenda MK, Malmström A, Lysiak M, Mudaisi M, Bratthäll C, Milos P, Strandeus M, Åkesson L, Söderkvist P, Uppugunduri S, Osman A.
Heenkenda MK, et al. Among authors: mudaisi m.
Thromb Res. 2019 Nov;183:136-142. doi: 10.1016/j.thromres.2019.10.009. Epub 2019 Oct 22.
Thromb Res. 2019.
PMID: 31677594
Free article.
Item in Clipboard
The sex-dependent role of the androgen receptor in glioblastoma: results of molecular analyses.
Łysiak M, Trybuła M, Mudaisi M, Bratthäll C, Strandeus M, Milos P, Hallbeck M, Malmström A.
Łysiak M, et al. Among authors: mudaisi m.
Mol Oncol. 2022 Oct;16(19):3436-3451. doi: 10.1002/1878-0261.13262. Epub 2022 Jun 22.
Mol Oncol. 2022.
PMID: 35661403
Free PMC article.
Item in Clipboard
Deletions on Chromosome Y and Downregulation of the SRY Gene in Tumor Tissue Are Associated with Worse Survival of Glioblastoma Patients.
Łysiak M, Smits A, Roodakker KR, Sandberg E, Dimberg A, Mudaisi M, Bratthäll C, Strandeus M, Milos P, Hallbeck M, Söderkvist P, Malmström A.
Łysiak M, et al. Among authors: mudaisi m.
Cancers (Basel). 2021 Mar 31;13(7):1619. doi: 10.3390/cancers13071619.
Cancers (Basel). 2021.
PMID: 33807423
Free PMC article.
Item in Clipboard
"Do I want to know it all?" A qualitative study of glioma patients' perspectives on receiving information about their diagnosis and prognosis.
Malmström A, Åkesson L, Milos P, Mudaisi M, Bruhn H, Strandeus M, Karlsson M.
Malmström A, et al. Among authors: mudaisi m.
Support Care Cancer. 2021 Jun;29(6):3339-3346. doi: 10.1007/s00520-020-05846-7. Epub 2020 Oct 30.
Support Care Cancer. 2021.
PMID: 33125538
Free PMC article.
Item in Clipboard
Cite
Cite